Megan Seifert
Family · Newburgh, INNPI 1609363852
Payments from drug & device makers
Across 164 payments — averaging $15.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$499
- Otsuka America Pharmaceutical, Inc.$446
- Alkermes, Inc.$230
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$193
- Lundbeck LLC$187
- Pfizer$138
- plus $782 from 16 others
What the payments were for
- Food & beverage$2,475100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 36 | $499 |
| Otsuka America Pharmaceutical, Inc. | 32 | $446 |
| Alkermes, Inc. | 14 | $230 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 11 | $193 |
| Lundbeck LLC | 15 | $187 |
| Pfizer | 8 | $138 |
| Axsome Therapeutics, Inc. | 10 | $124 |
| Tris Pharma Inc | 7 | $122 |
| Vanda Pharmaceuticals Inc. | 4 | $88 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $74 |
| Almatica Pharma LLC | 3 | $72 |
| Corium, LLC | 4 | $52 |
| Novo Nordisk | 3 | $44 |
| Indivior Inc. | 2 | $44 |
| Exact Sciences | 2 | $31 |
| Organon | 3 | $31 |
| Shield Therapeutics Inc | 1 | $21 |
| Astellas Pharma US Inc | 1 | $19 |
| GSK | 1 | $18 |
| AstraZeneca | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
| Currax Pharmaceuticals LLC | 1 | $13 |
How this compares
$2,475 in reported general payments places this provider in the 80th percentile of 4,392 family providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ondansetron Hcl | 96 | $232,264 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 114 | $15,541 |
| JardianceEmpagliflozin | 12 | $8,731 |
| Aripiprazole | 38 | $7,291 |
| Desvenlafaxine Succinate ErDesvenlafaxine Succinate | 28 | $5,809 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 31 | $4,898 |
| Cyclobenzaprine Hcl | 20 | $3,902 |
| Celecoxib | 30 | $2,634 |
| Quetiapine Fumarate ErQuetiapine Fumarate | 19 | $2,329 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 118 | $2,040 |
| Pioglitazone-MetforminPioglitazone Hcl/Metformin Hcl | 28 | $1,435 |
| Modafinil | 14 | $1,337 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 67 | $1,323 |
| Nebivolol Hcl | 23 | $1,239 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 15 | $878 |
Paid to pharmacies, not to this prescriber.
Other family in Newburgh
- Tina SizemoreIndianapolis$888K
- Kathalene Keller RineyEvansville$383K
- Robin AndersonPortage$333K
- Marla MosesIndianapolis$142K
- Justin BrownFort Wayne$142K
- Lacey MatheisEvansville$139K
- Myra SikwataHobart$131K
- Elizabeth JohnsonEvansville$108K
- Beverly MaugerFt Wayne$94K
- Nancy ArndtPortage$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.